Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche censured for drunken conference antics

February 21, 2013 Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
News

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
Feature

Pharma losing in ‘valley of death’

February 21, 2013 Research and Development, Sales and Marketing Bath, Evotec, pharma

An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …
News

Lundbeck elects new chairman

February 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck

Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …
Appointment

NHS Confederation appoints two directors

February 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation

The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …
Appointment

FDA accepts GSK’s Anoro

February 20, 2013 Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro

The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …
News

Phytopharm suffers Parkinson’s loss

February 20, 2013 Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane

Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …
News

Director-level role hire at Insight Research Group

February 20, 2013 Medical Communications, Research and Development, Sales and Marketing Insight Research Group, carolyn dodd

Carolyn Dodd has taken up a director-level position at healthcare consultancy firm Insight Research Group. Dodd previously spent 12 years …
Appointment

VBP negotiations ‘opened up’

February 19, 2013 Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …
News

Vasella forgoes golden handshake after furore

February 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …
News

inVentiv Health names new European head

February 19, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health

Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …
Appointment

EU orphan designations rise

February 19, 2013 Research and Development, Sales and Marketing COMP, EMA, Orphan, hta

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …
News

ViiV HIV drug boost

February 18, 2013 Sales and Marketing Dolutegravir, GSK, HIV, ViiV

ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …
News

Merck makes $688m payout

February 18, 2013 Sales and Marketing ENHANCE, Inegy, Merck, Vytorin, investors

Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …
News

Another approval for Novartis’ everolimus

February 18, 2013 Sales and Marketing Certican, Novartis, Zortress, everolimus

Novartis has gained US approval for its drug Zortress (everolimus) to prevent liver transplant rejection.Zotress is already used to prevent …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026